Skip to Content
Merck
  • Activated αIIbβ3 on platelets mediates flow-dependent NETosis via SLC44A2.

Activated αIIbβ3 on platelets mediates flow-dependent NETosis via SLC44A2.

eLife (2020-04-22)
Adela Constantinescu-Bercu, Luigi Grassi, Mattia Frontini, Isabelle I Salles-Crawley, Kevin Woollard, James Tb Crawley
ABSTRACT

Platelet-neutrophil interactions are important for innate immunity, but also contribute to the pathogenesis of deep vein thrombosis, myocardial infarction and stroke. Here we report that, under flow, von Willebrand factor/glycoprotein Ibα-dependent platelet 'priming' induces integrin αIIbβ3 activation that, in turn, mediates neutrophil and T-cell binding. Binding of platelet αIIbβ3 to SLC44A2 on neutrophils leads to mechanosensitive-dependent production of highly prothrombotic neutrophil extracellular traps. A polymorphism in SLC44A2 (rs2288904-A) present in 22% of the population causes an R154Q substitution in an extracellular loop of SLC44A2 that is protective against venous thrombosis results in severely impaired binding to both activated αIIbβ3 and VWF-primed platelets. This was confirmed using neutrophils homozygous for the SLC44A2 R154Q polymorphism. Taken together, these data reveal a previously unreported mode of platelet-neutrophil crosstalk, mechanosensitive NET production, and provide mechanistic insight into the protective effect of the SLC44A2 rs2288904-A polymorphism in venous thrombosis.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Diphenyleneiodonium chloride, ≥98%
Supelco
Tetrahydrocannabivarinic acid (THCVA) solution, 1.0 mg/mL in acetonitrile, certified reference material, ampule of 1 mL, Cerilliant®
Sigma-Aldrich
Nitrilotriacetic acid disodium salt, Sigma Grade, ≥99%